Ligand · 0BY
0BY · 4-({4-[(2-chlorophenyl)amino]pyrimidin-2-yl}amino)benzoic acid
0BY, 4-({4-[(2-chlorophenyl)amino]pyrimidin-2-yl}amino)benzoic acid (C17 H13 Cl N4 O2, 340.8 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues…
- Component
- 0BY
- Formula
- C17 H13 Cl N4 O2
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
0BY in 4 structures; the first of them:
- 3UNK · CDK2 in complex with inhibitor YL5-083 · 0BY A299 · binds ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82 and 10 more
- 3UO6 · Aurora A in complex with YL5-083 · 0BY A1 · binds ARG137, LEU139, GLY140, VAL147, ALA160, LEU194, GLU211, TYR212 and 10 more
- 3UNK · CDK2 in complex with inhibitor YL5-083 · 0BY A299 · binds ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82 and 10 more
- 3UO6 · Aurora a in complex with YL5-083 · 0BY A1 · binds ARG137, LEU139, GLY140, VAL147, ALA160, LEU194, GLU211, TYR212 and 10 more
Residues it binds most
ALA 6, LEU 6, VAL 6, GLU 6, GLY 4, HIS 6, ARG 4, ASP 2, GLN 2, LYS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.